Bryan King

Bryan King is a Professor in the Department of Psychiatry at the University of California, San Francisco (UCSF) School of Medicine and Director of the UCSF Weill Institute for Neurosciences. His clinical and research work focuses on psychiatric aspects of developmental disorders, particularly autism spectrum disorder (ASD), with emphasis on psychopharmacological and psychosocial interventions for behavioral disturbances.

• Education: BS in Biological Sciences (1979) from UC Irvine, MD in Medicine (1983) from Medical College of Wisconsin, MBA (2014) from George Washington University.
• Key Grants: Principal Investigator on multiple NIH-funded studies including R01MH086927 (Guanfacine for Hyperactivity in PDD), P50HD055782 (UW Autism Center of Excellence), and R01HD033779 (Self-Injurious Behavior in Mental Retardation).

Research Trends: Recent publications highlight pharmacological treatments (e.g., oxytocin, guanfacine), comorbidities in ASD (anxiety, sleep disorders), and neurogenetic syndromes. His work bridges clinical trials, neurobiology (cerebellar pathology, serotonin mechanisms), and behavioral science.

• Scientific Awards: Phi Beta Kappa, Magna Cum Laude, NIMH Individual Research Service Award, Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry, Beta Gamma Sigma Honor Society.
• Advising: Mentored numerous studies on ASD interventions, including clinical trials for pharmacological agents like arbaclofen and citalopram.